Phase II Study Evaluating the Association of Bevacizumab and Chemotherapy of the Type Modified FOLFIRI 3 in Patients With Metastatic Colorectal Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2016
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Therapeutic Use
- 30 Oct 2007 New trial record.